SXTP
NASDAQ · Pharmaceuticals
60 Degrees Pharma Inc
$1.61
-0.22 (-12.02%)
Open$1.81
Previous Close$1.83
Day High$1.84
Day Low$1.53
52W High$17.68
52W Low$1.36
Volume—
Avg Volume6.49M
Market Cap4.77M
P/E Ratio—
EPS$-15.22
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+65.2% upside
Current
$1.61
$1.61
Target
$2.66
$2.66
$2.13
$2.66 avg
$3.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.67M | 30.89M | 862.6K |
| Net Income | -171,150,327 | -324,216,573 | 198.9K |
| Profit Margin | -1,166.4% | -1,108.1% | 23.1% |
| EBITDA | -206,784,719 | -413,482,389 | 334.7K |
| Free Cash Flow | — | — | 224.8K |
| Rev Growth | -52.5% | -52.5% | -6.7% |
| Debt/Equity | 0.04 | 0.04 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |